— Know what they know.
Not Investment Advice
Also trades as: NRXPW (NASDAQ) · $vol 0M

NRXP NASDAQ

NRx Pharmaceuticals, Inc.
1W: -3.0% 1M: -15.9% 3M: -26.3% YTD: +11.1% 1Y: -12.9% 3Y: +15.9% 5Y: -96.9%
$2.90
+0.06 (+1.93%)
 
Weekly Expected Move ±5.0%
$3 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $125.8M mcap · 37M float · 2.85% daily turnover · Short 38% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 61.3%
Cost Advantage
49
Intangibles
26
Switching Cost
60
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NRXP shows a Weak competitive edge (41.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 61.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2022-06-30 H.C. Wainwright Vernon Bernardino Initiated $2 — +249.0% $0.57

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 02, 2026
DCF
3
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NRXP receives an overall rating of C+. Strongest factors: ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-25 C- C+
2026-03-24 D+ C-
2026-03-24 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 19 Grade D
Profitability
7
Balance Sheet
9
Earnings Quality
38
Growth
—
Value
15
Momentum
—
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NRXP scores highest in Earnings Quality (38/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-12.85
Distress Zone
Piotroski F-Score
5/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
-0.88
Bankruptcy prob: 29.3%
Moderate
Credit Rating
CCC
Score: 17.2/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.84x
Accruals: -19.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NRXP scores -12.85, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NRXP scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NRXP's implied 29.3% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NRXP receives an estimated rating of CCC (score: 17.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.91x
PEG
-0.03x
P/S
37.06x
P/B
-643.36x
P/FCF
-7.45x
P/OCF
—
EV/EBITDA
-5.85x
EV/Revenue
37.87x
EV/EBIT
-5.76x
EV/FCF
-6.22x
Earnings Yield
-15.25%
FCF Yield
-13.42%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NRXP currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.051
EBT / EBIT
×
EBIT Margin
-6.581
EBIT / Rev
×
Asset Turnover
0.174
Rev / Assets
×
Equity Multiplier
-1.090
Assets / Equity
=
ROE
131.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NRXP's ROE of 131.2% is driven by Asset Turnover (0.174), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.91
Median 1Y
$0.87
5th Pctile
$0.12
95th Pctile
$6.19
Ann. Volatility
119.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jonathan Javitt Officer,
ecutive Officer, Chief Scientist and Chairman
$575,000 $— $825,000
Richard Narido Financial
ief Financial Officer
$435,032 $— $435,032
Stephen Willard
Former Chief Executive Officer
$395,833 $— $395,833
Matthew Duffy Business
siness Officer
$338,000 $— $338,000
Michael Abrams Financial
ancial Officer
$20,313 $— $20,313

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $825,000
Avg Employee Cost (SGA/emp): $450,379
Employees: 29

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
29
+866.7% YoY
Revenue / Employee
$42,241
Rev: $1,225,000
Profit / Employee
$-986,966
NI: $-28,622,000
SGA / Employee
$450,379
Avg labor cost proxy
R&D / Employee
$130,241
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -17.7% 8.1% -4.9% -22.3% -4.7% -2.8% -2.4% -3.5% -6.8% 13.9% 3.3% 2.3% 1.6% 1.4% 1.2% 1.3% 1.7% 1.5% 1.3% 1.3% 1.31%
ROA -4.2% -5.2% -3.3% -3.5% -1.7% -1.4% -1.1% -1.5% -1.9% -1.8% -2.0% -2.0% -2.3% -4.6% -4.2% -6.7% -3.9% -3.4% -2.5% -1.2% -1.20%
ROIC 1.4% 12.0% 10.5% -96.7% 47.1% 16.5% 6.5% 5.7% 5.2% 3.0% 2.0% 1.6% 1.2% 86.1% 62.1% 39.7% 36.9% 55.4% 68.9% 61.3% 61.30%
ROCE -12.0% -4.5% -2.6% -3.5% -3.6% -3.9% 131.5% 13.9% 5.8% 2.6% 1.7% 1.3% 1.2% 1.3% 92.4% 94.9% 1.5% 1.8% 1.8% -78.1% -78.10%
Gross Margin — — — — — — — — — — — — — — — — 59.9% 48.3% 25.5% 23.4% 23.43%
Operating Margin — — — — — — — — — — — — — — — — -16.6% -4.7% -4.4% -5.9% -5.91%
Net Margin — — — — — — — — — — — — — — — — -24.3% 36.6% -1.3% -15.0% -15.00%
EBITDA Margin — — — — — — — — — — — — — — — — -24.2% 1.2% -96.6% -14.7% -14.73%
FCF Margin — — — — — — — — — — — — — — — — -49.0% -11.5% -6.5% -6.1% -6.09%
OCF Margin — — — — — — — — — — — — — — — — -49.0% -11.5% -6.5% -5.8% -5.83%
ROA 3Y Avg snapshot only -4.13%
ROIC Economic snapshot only -15.57%
Cash ROA snapshot only -57.89%
NOPAT Margin snapshot only -4.63%
Pretax Margin snapshot only -6.92%
R&D / Revenue snapshot only 1.59%
SGA / Revenue snapshot only 4.65%
SBC / Revenue snapshot only 10.93%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -47.14 -26.47 -19.16 -4.47 -8.15 -18.55 -11.90 -9.07 -0.59 -12.80 -1.63 -1.03 -0.91 -0.92 -1.40 -1.73 -1.93 -3.00 -2.81 -6.56 -3.910
P/S Ratio — — — — — — — — — — — — — — — — 303.15 70.20 30.03 45.37 37.058
P/B Ratio 566.60 118.87 49.22 15.56 29.30 99.56 -1565.22 -126.21 -3.43 -32.90 -2.77 -1.40 -0.99 -1.00 -1.34 -1.64 -2.85 -5.40 -4.98 -905.80 -643.361
P/FCF -171.22 -61.00 -32.55 -8.14 -11.51 -18.55 -12.53 -12.44 -0.80 -17.82 -2.17 -1.72 -1.46 -2.11 -3.13 -5.18 -6.18 -6.09 -4.61 -7.45 -7.449
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -46.79 -26.18 -18.68 -4.19 -7.85 -18.32 -11.79 -9.01 -0.62 -13.01 -1.87 -1.37 -1.23 -1.18 -1.57 -1.95 -1.75 -2.83 -2.70 -5.85 -5.853
EV/Revenue — — — — — — — — — — — — — — — — 274.90 64.35 27.51 37.87 37.874
EV/EBIT -46.79 -26.18 -18.68 -4.19 -7.85 -18.32 -11.79 -9.01 -0.62 -13.01 -1.87 -1.37 -1.23 -1.18 -1.57 -1.95 -1.75 -2.82 -2.67 -5.76 -5.755
EV/FCF -169.93 -60.33 -31.73 -7.63 -11.08 -18.31 -12.41 -12.36 -0.84 -18.03 -2.46 -2.17 -1.86 -2.58 -3.39 -5.83 -5.61 -5.59 -4.23 -6.22 -6.219
Earnings Yield -2.1% -3.8% -5.2% -22.4% -12.3% -5.4% -8.4% -11.0% -1.7% -7.8% -61.4% -96.7% -1.1% -1.1% -71.7% -57.8% -51.9% -33.3% -35.6% -15.2% -15.25%
FCF Yield -0.6% -1.6% -3.1% -12.3% -8.7% -5.4% -8.0% -8.0% -1.3% -5.6% -46.0% -58.2% -68.3% -47.3% -32.0% -19.3% -16.2% -16.4% -21.7% -13.4% -13.42%
EV/Gross Profit snapshot only 111.779
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.25 2.74 3.66 4.58 3.08 1.66 0.99 0.87 0.68 0.36 0.18 0.21 0.20 0.15 0.22 0.11 0.29 0.31 0.29 0.86 0.861
Quick Ratio 1.25 2.74 3.66 4.58 3.08 1.66 0.99 0.87 0.68 0.36 0.18 0.21 0.20 0.15 0.22 0.11 0.29 0.31 0.29 0.86 0.861
Debt/Equity 0.06 0.02 0.02 0.00 0.00 1.42 -42.92 -4.52 -1.62 -0.78 -0.45 -0.47 -0.35 -0.28 -0.33 -0.29 -0.01 -0.04 -0.07 -7.33 -7.329
Net Debt/Equity -4.28 -1.30 -1.25 -0.97 -1.09 -1.29 — — — — — — — — — — — — — — —
Debt/Assets 0.01 0.02 0.01 0.00 0.00 0.41 0.56 0.64 0.77 1.25 1.79 1.63 1.49 1.80 1.11 2.11 0.02 0.05 0.08 0.04 0.036
Debt/EBITDA -0.00 -0.01 -0.01 -0.00 -0.00 -0.26 -0.33 -0.32 -0.28 -0.31 -0.27 -0.36 -0.35 -0.27 -0.36 -0.30 -0.01 -0.02 -0.04 -0.06 -0.057
Net Debt/EBITDA 0.36 0.29 0.49 0.28 0.30 0.24 0.12 0.06 -0.03 -0.15 -0.22 -0.28 -0.26 -0.21 -0.12 -0.22 0.18 0.26 0.25 1.16 1.158
Interest Coverage -5345.93 -5243.35 -5145.22 -8239.51 -11283.82 -13250.33 — — -900.48 -250.25 -72.25 -19.70 -16.58 -22.29 -27.40 — — -41.66 -26.15 -19.52 -19.524
Equity Multiplier 5.05 1.57 1.38 1.28 1.48 3.48 -76.69 -7.05 -2.11 -0.62 -0.25 -0.29 -0.24 -0.16 -0.30 -0.14 -0.58 -0.81 -0.86 -200.94 -200.941
Cash Ratio snapshot only 0.788
Debt Service Coverage snapshot only -19.198
Cash to Debt snapshot only 21.417
FCF to Debt snapshot only -16.590
Defensive Interval snapshot only 466.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.15 0.24 0.17 0.174
Inventory Turnover — 0.02 — — — — — — — — — — — — — — — — — — —
Receivables Turnover — 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.98 15.22 25.34 32.95 32.951
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.14 0.32 0.66 0.662
DSO — — — — — — — — — — — — — — — — 185 24 14 11 11.1 days
DIO 0 19528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 406650 624150 262252 562382 415391 262937 368969 241037 211664 244842 366496 263530 310140 319813 482530 525904 16989 2534 1135 551 551.1 days
Cash Conversion Cycle — — — — — — — — — — — — — — — — -16804 -2510 -1120 -540 -540.0 days
Fixed Asset Turnover snapshot only 1.938
Cash Velocity snapshot only 0.127
Capital Intensity snapshot only 10.065
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — — — — — — — — — — — — —
Net Income -21.5% -87.2% -7.6% -16.3% 44.0% 57.5% 54.1% 55.7% 40.2% 24.2% 31.3% 36.5% 43.5% 16.7% 6.0% -36.2% -86.8% -13.9% -1.8% 30.5% 30.52%
EPS -46.1% 90.2% 39.8% 24.8% 53.8% 66.9% 56.7% 60.3% -3.8% 39.9% -4.2% -3.4% 57.8% -5.6% 49.3% 20.2% 7.8% 62.2% 48.3% 66.9% 66.90%
FCF -13.0% -16.9% -8.2% -1.6% -44.0% 1.9% 26.0% 41.2% 37.3% 45.5% 45.8% 47.6% 52.7% 49.5% 44.1% 24.5% 6.4% -28.9% -38.8% -83.3% -83.29%
EBITDA -21.8% -87.5% -7.6% -16.3% 44.0% 57.5% 54.1% 55.7% 40.3% 24.5% 32.3% 39.6% 46.6% 19.9% 8.0% -43.1% -97.8% -15.7% -0.3% 35.0% 35.01%
Op. Income -4.2% -3.6% -3.1% -1.4% -64.7% 53.4% 64.1% 63.0% 62.2% 37.8% 36.6% 36.1% 38.1% 28.6% 27.3% 38.8% 25.6% 17.8% 2.6% -39.6% -39.61%
OCF Growth snapshot only -75.33%
Asset Growth snapshot only 6.06%
Debt Growth snapshot only -87.82%
Shares Change snapshot only 1.10%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -13.5% -22.7% -15.3% -13.5% -15.9% -7.0% 51.4% 46.7% 29.5% 35.5% -14.3% -34.3% -53.8% -51.9% -44.2% -47.0% -15.5% -20.5% -18.2% 19.9% 19.92%
Assets 5Y — — — — — -18.0% -20.7% -22.2% -28.4% -36.5% -44.5% -36.3% -36.0% -35.2% 3.9% -5.1% 20.0% 34.5% 14.6% 13.0% 12.99%
Equity 3Y -49.5% -33.1% -23.1% -19.2% -24.7% -36.9% — — — — — — — — — — — — — — —
Book Value 3Y -81.7% -74.9% -73.1% -71.8% -73.8% -87.5% — — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.41 0.41 0.41 0.41 0.409
Earnings Stability 0.63 0.79 0.76 0.78 0.56 0.55 0.49 0.50 0.33 0.23 0.14 0.13 0.04 0.00 0.01 0.00 0.03 0.45 0.78 0.72 0.723
Margin Stability — — — — — — — — — — — — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.82 0.50 0.50 0.50 0.84 0.90 0.87 0.85 0.83 0.93 0.98 0.86 0.50 0.94 0.99 0.88 0.878
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -11.28 — 28.38 — 3.17 — — — — — — — — — — — — — — — —
Gross Margin Trend — — — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.28 0.43 0.59 0.55 0.71 1.00 0.95 0.73 0.74 0.72 0.75 0.60 0.62 0.44 0.45 0.33 0.31 0.49 0.61 0.84 0.842
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.05 1.045
FCF/Net Income snapshot only 0.880
CapEx/Revenue — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 26.4% 26.43%
CapEx/Depreciation snapshot only 2.398
Accruals Ratio -3.05 -2.97 -1.35 -1.56 -0.50 0.00 -0.06 -0.41 -0.49 -0.51 -0.50 -0.79 -0.88 -2.59 -2.35 -4.46 -2.69 -1.75 -0.99 -0.19 -0.190
Sloan Accruals snapshot only 1.578
Cash Flow Adequacy snapshot only -22.045
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.0% -2.1% -4.3% -13.0% -4.6% -3.1% -0.5% -2.3% -44.0% -2.4% -22.3% -26.7% -31.9% -16.6% -13.5% -4.2% -16.6% -18.4% -23.3% -28.7% -28.66%
Total Shareholder Return -1.0% -2.1% -4.3% -13.0% -4.6% -3.1% -0.5% -2.3% -44.0% -2.4% -22.3% -26.7% -31.9% -16.6% -13.5% -4.2% -16.6% -18.4% -23.3% -28.7% -28.66%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.05 1.06 1.04 1.04 1.00 1.00 1.02 1.04 1.05 1.051
EBIT Margin — — — — — — — — — — — — — — — — -157.28 -22.82 -10.31 -6.58 -6.581
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.15 0.24 0.17 0.174
Equity Multiplier 4.21 -1.55 1.51 6.44 2.72 2.07 2.08 2.32 3.59 -7.66 -1.67 -1.18 -0.70 -0.31 -0.28 -0.19 -0.44 -0.42 -0.50 -1.09 -1.090
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.97 $-1.81 $-1.28 $-1.34 $-0.91 $-0.60 $-0.55 $-0.53 $-4.40 $-0.36 $-2.90 $-2.36 $-1.86 $-2.39 $-1.47 $-1.88 $-1.71 $-0.90 $-0.76 $-0.62 $-0.62
Book Value/Share $0.16 $0.40 $0.50 $0.39 $0.25 $0.11 $-0.00 $-0.04 $-0.76 $-0.14 $-1.70 $-1.75 $-1.72 $-2.21 $-1.53 $-1.99 $-1.16 $-0.50 $-0.43 $-0.00 $-0.00
Tangible Book/Share $0.16 $0.40 $0.50 $0.39 $0.25 $0.11 $-0.00 $-0.04 $-0.76 $-0.14 $-1.70 $-1.75 $-1.72 $-2.21 $-1.53 $-1.99 $-1.27 $-0.59 $-0.51 $-0.07 $-0.07
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.04 $0.07 $0.09 $0.09
FCF/Share $-0.54 $-0.78 $-0.75 $-0.74 $-0.64 $-0.60 $-0.53 $-0.39 $-3.27 $-0.26 $-2.17 $-1.42 $-1.15 $-1.04 $-0.66 $-0.63 $-0.53 $-0.44 $-0.46 $-0.55 $-0.55
OCF/Share $-0.54 $-0.78 $-0.75 $-0.74 $-0.64 $-0.60 $-0.53 $-0.39 $-3.27 $-0.26 $-2.17 $-1.42 $-1.15 $-1.04 $-0.66 $-0.63 $-0.53 $-0.44 $-0.46 $-0.53 $-0.53
Cash/Share $0.71 $0.53 $0.63 $0.37 $0.27 $0.30 $0.24 $0.20 $1.09 $0.05 $0.15 $0.18 $0.15 $0.14 $0.34 $0.16 $0.32 $0.25 $0.21 $0.71 $0.71
EBITDA/Share $-1.97 $-1.81 $-1.28 $-1.34 $-0.91 $-0.60 $-0.55 $-0.53 $-4.39 $-0.36 $-2.86 $-2.25 $-1.75 $-2.29 $-1.42 $-1.88 $-1.71 $-0.88 $-0.72 $-0.58 $-0.58
Debt/Share $0.01 $0.01 $0.01 $0.00 $0.00 $0.16 $0.18 $0.17 $1.23 $0.11 $0.77 $0.82 $0.61 $0.63 $0.51 $0.57 $0.02 $0.02 $0.03 $0.03 $0.03
Net Debt/Share $-0.70 $-0.52 $-0.62 $-0.37 $-0.27 $-0.14 $-0.06 $-0.03 $0.14 $0.05 $0.62 $0.64 $0.46 $0.49 $0.17 $0.41 $-0.31 $-0.23 $-0.18 $-0.68 $-0.68
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -12.846
Altman Z-Prime snapshot only -31.591
Piotroski F-Score 3 4 4 4 4 1 2 2 3 1 2 2 2 2 4 1 5 5 5 5 5
Beneish M-Score — — — — — — — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only -0.880
Net-Net WC snapshot only $-0.14
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 53.66 60.65 61.98 69.65 69.84 57.67 20.00 20.00 15.34 12.73 12.84 12.75 12.88 12.87 12.84 20.00 20.00 12.89 12.73 17.22 17.224
Credit Grade snapshot only 17
Credit Trend snapshot only -2.776
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 7
Sector Credit Rank snapshot only 7

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms